K. Nath, J. Burel, V. Shankar, A. Pritchard, M. Towers et al., Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease, International Journal of Chronic Obstructive Pulmonary Disease, vol.9, pp.51-57, 2014.
DOI : 10.2147/COPD.S53590

G. Gorse, O. Connor, T. Newman, F. Mandava, M. Mendelman et al., Immunity to Influenza in Older Adults with Chronic Obstructive Pulmonary Disease, The Journal of Infectious Diseases, vol.190, issue.1, pp.11-20, 2004.
DOI : 10.1086/421121

N. Hanania, M. Sockrider, M. Castro, J. Holbrook, J. Tonascia et al., Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy, Journal of Allergy and Clinical Immunology, vol.113, issue.4
DOI : 10.1016/j.jaci.2003.12.584

P. Wongsurakiat, K. Maranetra, P. Gulprasutdilog, M. Aksornint, W. Srilum et al., Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study, Respirology, vol.100, issue.4, pp.550-556, 2004.
DOI : 10.1164/ajrccm.152.3.7663792

S. Ting, S. Crooks, and G. South, The effect of influenza vaccination on the incidence of chronic obstructive pulmonary disease exacerbations in the immediate postvaccination period, Journal of Epidemiology & Community Health, vol.65, issue.2, pp.157-166, 2011.
DOI : 10.1136/jech.2009.092296

P. Wongsurakiat, K. Maranetra, C. Wasi, U. Kositanont, W. Dejsomritrutai et al., Acute Respiratory Illness in Patients With COPD and the Effectiveness of Influenza Vaccination, Chest, vol.125, issue.6, pp.2011-2031, 2004.
DOI : 10.1378/chest.125.6.2011

C. Anar, C. Bicmen, S. Yapicioglu, I. Unsal, H. Halilcolar et al., Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease, The new microbiologica, vol.33, pp.117-144, 2010.

J. Hedlund, B. Christenson, P. Lundbergh, and A. Ortqvist, Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up, Vaccine, vol.21, issue.25-26, pp.3906-3917, 2003.
DOI : 10.1016/S0264-410X(03)00296-2

S. Schembri, S. Morant, J. Winter, and T. Macdonald, Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD, Thorax, vol.64, issue.7, pp.567-72, 2009.
DOI : 10.1136/thx.2008.106286

C. Lai, L. Lee, C. Yu, P. Hsueh, P. Yang et al., Antibody Responses to Pneumococcal Polysaccharide Vaccine in Taiwanese Patients with Chronic Obstructive Pulmonary Disease, Journal of the Formosan Medical Association, vol.106, issue.3, pp.196-203, 2007.
DOI : 10.1016/S0929-6646(09)60240-0

A. De-roux, N. Schmidt, M. Rose, S. Zielen, M. Pletz et al., Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids, Respiratory Medicine, vol.98, issue.12, pp.1187-94, 2004.
DOI : 10.1016/j.rmed.2004.04.012

J. Steentoft, H. Konradsen, J. Hilskov, G. Gislason, and J. Andersen, Response to pneumococcal vaccine in chronic obstructive lung disease???The effect of ongoing, systemic steroid treatment, Vaccine, vol.24, issue.9, pp.1408-1420, 2006.
DOI : 10.1016/j.vaccine.2005.09.020

M. Dransfield, M. Nahm, M. Han, S. Harnden, G. Criner et al., Superior Immune Response to Protein-Conjugate versus Free Pneumococcal Polysaccharide Vaccine in Chronic Obstructive Pulmonary Disease, American Journal of Respiratory and Critical Care Medicine, vol.180, issue.6, pp.499-505, 2009.
DOI : 10.1164/rccm.200903-0488OC

M. Dransfield, S. Harnden, R. Burton, R. Albert, W. Bailey et al., Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease. Clinical infectious diseases : an official publication of the Infectious Diseases Society of, America, vol.55, pp.35-44, 2012.

J. Schenkein, M. Nahm, and M. Dransfield, Pneumococcal Vaccination for Patients With COPD, Chest, vol.133, issue.3, pp.767-74, 2008.
DOI : 10.1378/chest.07-0996

A. Furumoto, Y. Ohkusa, M. Chen, K. Kawakami, H. Masaki et al., Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease, Vaccine, vol.26, issue.33, pp.4284-4293, 2008.
DOI : 10.1016/j.vaccine.2008.05.037

M. Sumitani, Y. Tochino, T. Kamimori, H. Fujiwara, and T. Fujikawa, Additive Inoculation of Influenza Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine to Prevent Lower Respiratory Tract Infections in Chronic Respiratory Disease Patients, Internal Medicine, vol.47, issue.13, pp.1189-97, 2008.
DOI : 10.2169/internalmedicine.47.0799

I. Alfageme, R. Vazquez, N. Reyes, J. Munoz, A. Fernandez et al., Clinical efficacy of anti-pneumococcal vaccination in patients with COPD, Thorax, vol.61, issue.3, pp.189-95, 2006.
DOI : 10.1136/thx.2005.043323

N. French, S. Gordon, T. Mwalukomo, S. White, G. Mwafulirwa et al., A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults, New England Journal of Medicine, vol.362, issue.9, pp.812-834, 2010.
DOI : 10.1056/NEJMoa0903029

R. Lazarus, E. Clutterbuck, L. Yu, J. Bowman, E. Bateman et al., A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adults. Clinical infectious diseases : an official publication of the Infectious Diseases Society of, America, vol.52, pp.736-778, 2011.

M. Bonten, S. Huijts, M. Bolkenbaas, C. Webber, S. Patterson et al., Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults, New England Journal of Medicine, vol.372, issue.12
DOI : 10.1056/NEJMoa1408544